Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report

Personal neoantigen vaccines are considered to be effective methods for inducing, amplifying and diversifying antitumor T cell responses. We recently conducted a clinical study that combined neoantigen nanovaccine with anti-PD-1 antibody. Here, we reported a case with a clear beneficial outcome from...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Jie, Liu, Qin, Shen, Jie, Qian, Xiaoping, Yan, Jing, Zhu, Yahui, Qiu, Xin, Lu, Changchang, Cen, Lanqi, Tian, Manman, Du, Juan, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901600/
https://www.ncbi.nlm.nih.gov/pubmed/35273594
http://dx.doi.org/10.3389/fimmu.2022.799026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901600/
https://www.ncbi.nlm.nih.gov/pubmed/35273594
http://dx.doi.org/10.3389/fimmu.2022.799026

Ejemplares similares